Report - First-in-human phase I clinical trial of the NY-ESO-1 ... · Cancer Immunology, Immunotherapy (2020) 69:663–675 667 1 3 D‑elated adverse events Thedrug-relatedAEsreportedinthisstudyareshownin

Please pass captcha verification before submit form